 |
|
Exaggerated Messenger RNA Expression of Inflammatory Cytokines in Human T-Cell Lymphotropic Virus Type I—Associated Myelopathy
Hiroko Watanabe, MD;
Tatsufumi Nakamura, MD;
Kunihiko Nagasato, MD;
Susumu Shirabe, MD;
Kiyosumi Ohishi, MD;
Katsuhiro Ichinose, MD;
Yoshihiro Nishiura, MD;
Shin Chiyoda, MD;
Mitsuhiro Tsujihata, MD;
Shigenobu Nagataki, MD
Arch Neurol. 1995;52(3):276-280.
Abstract
Objective
To investigate the expression of inflammatory cytokine messenger RNA (mRNA) in peripheral blood mononuclear cells of patients with human T-cell lymphotropic virus type I (HTLV-I)—associated myelopathy (HAM).
Patients
Seventeen patients with HAM, 18 HTLV-I—seropositive carriers, and 10 seronegative individuals were studied.
Main Outcome Measure
We compared the expression of tumor necrosis factor  (TNF-), granulocytemacrophage colony-stimulating factor (GM-CSF), interferon alpha (IFN-), IFN-β, and IFN- , and interleukin 1 (IL-1) and IL-1β by reverse transcriptase—polymerase chain reaction.
Results
In patients with HAM, the reverse transcriptase—polymerase chain reaction products of TNF-, GM-CSF, IFN-, and IL-1 were detected in significantly higher incidences than in HTLV-I—seropositive carriers and seronegative controls. Furthermore, simultaneous mRNA expression of three or more of these four cytokines was detected in all patients with HAM compared with only 21.4% of HTLV-I—seropositive carriers. By contrast, there was no significant difference in mRNA expression of IFN-, IFN-β, and IL-1 β among patients with HAM, HTLV-I—seropositive carriers, and HTLV-I—seronegative controls.
Conclusions
An exaggerated mRNA expression of several inflammatory cytokines, including TNF-, GM-CSF, IFN-, and IL-1, was demonstrated in peripheral blood mononuclear cells of patients with HAM. Moreover, transcripts of these cytokines were simultaneously up-regulated in patients with HAM, suggesting that an inflammatory state in the central nervous system may be related to the pathogenesis of HAM.
Author Affiliations
From the First Department of Internal Medicine, Nagasaki (Japan) University School of Medicine (Drs Watanabe, Nakamura, Nagasato, Shirabe, Ohishi, Ichinose, Nishiura, and Nagataki); the Nagasaki Atomic Bomb Hospital, Japan Red Cross (Dr Chiyoda); and School of Allied Medical Sciences, Nagasaki University (Dr Tsujihata).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease
Oh et al.
Blood 2011;117:3363-3369.
ABSTRACT
| FULL TEXT
Different Cytokine Production in Tax-Expressing Cells between Patients with Human T Cell Lymphotropic Virus Type I (HTLV-I)-Associated Myelopathy/Tropical Spastic Paraparesis and Asymptomatic HTLV-I Carriers
Furukawa et al.
The Journal of Infectious Disease 2003;187:1116-1125.
ABSTRACT
| FULL TEXT
Common Human T Cell Leukemia Virus Type 1 (HTLV-1) Integration Sites in Cerebrospinal Fluid and Blood Lymphocytes of Patients with HTLV-1--Associated Myelopathy/Tropical Spastic Paraparesis Indicate that HTLV-1 Crosses the Blood-Brain Barrier via Clonal HTLV-1--Infected Cells
Cavrois et al.
The Journal of Infectious Disease 2000;182:1044-1050.
ABSTRACT
| FULL TEXT
|
